These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 15649822

  • 1. Dimethylfumarate for psoriasis: more than a dietary curiosity.
    Mrowietz U, Asadullah K.
    Trends Mol Med; 2005 Jan; 11(1):43-8. PubMed ID: 15649822
    [Abstract] [Full Text] [Related]

  • 2. Fumaric acid esters.
    Rostami Yazdi M, Mrowietz U.
    Clin Dermatol; 2008 Jan; 26(5):522-6. PubMed ID: 18755371
    [Abstract] [Full Text] [Related]

  • 3. Dimethylfumarate is a potent inducer of apoptosis in human T cells.
    Treumer F, Zhu K, Gläser R, Mrowietz U.
    J Invest Dermatol; 2003 Dec; 121(6):1383-8. PubMed ID: 14675187
    [Abstract] [Full Text] [Related]

  • 4. Use of fumaric acid esters in psoriasis.
    Roll A, Reich K, Boer A.
    Indian J Dermatol Venereol Leprol; 2007 Dec; 73(2):133-7. PubMed ID: 17456929
    [Abstract] [Full Text] [Related]

  • 5. Dimethylfumarate is an inhibitor of cytokine-induced E-selectin, VCAM-1, and ICAM-1 expression in human endothelial cells.
    Vandermeeren M, Janssens S, Borgers M, Geysen J.
    Biochem Biophys Res Commun; 1997 May 08; 234(1):19-23. PubMed ID: 9168952
    [Abstract] [Full Text] [Related]

  • 6. Dimethylfumarate inhibits tumor-necrosis-factor-induced CD62E expression in an NF-kappa B-dependent manner.
    Loewe R, Pillinger M, de Martin R, Mrowietz U, Gröger M, Holnthoner W, Wolff K, Wiegrebe W, Jirovsky D, Petzelbauer P.
    J Invest Dermatol; 2001 Dec 08; 117(6):1363-8. PubMed ID: 11886496
    [Abstract] [Full Text] [Related]

  • 7. Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data.
    Landeck L, Asadullah K, Amasuno A, Pau-Charles I, Mrowietz U.
    Arch Dermatol Res; 2018 Aug 08; 310(6):475-483. PubMed ID: 29574575
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of dendritic cell differentiation by fumaric acid esters.
    Zhu K, Mrowietz U.
    J Invest Dermatol; 2001 Feb 08; 116(2):203-8. PubMed ID: 11179994
    [Abstract] [Full Text] [Related]

  • 9. Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate.
    Oehrl S, Olaru F, Kunze A, Maas M, Pezer S, Schmitz M, Schäkel K.
    J Dermatol Sci; 2017 Sep 08; 87(3):278-284. PubMed ID: 28732748
    [Abstract] [Full Text] [Related]

  • 10. Dimethylfumarate inhibits nuclear binding of nuclear factor kappaB but not of nuclear factor of activated T cells and CCAAT/enhancer binding protein beta in activated human T cells.
    Gerdes S, Shakery K, Mrowietz U.
    Br J Dermatol; 2007 May 08; 156(5):838-42. PubMed ID: 17381463
    [Abstract] [Full Text] [Related]

  • 11. A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis.
    Brück J, Dringen R, Amasuno A, Pau-Charles I, Ghoreschi K.
    Exp Dermatol; 2018 Jun 08; 27(6):611-624. PubMed ID: 29603404
    [Abstract] [Full Text] [Related]

  • 12. Effects of monomethylfumarate on dendritic cell differentiation.
    Litjens NH, Rademaker M, Ravensbergen B, Thio HB, van Dissel JT, Nibbering PH.
    Br J Dermatol; 2006 Feb 08; 154(2):211-7. PubMed ID: 16433787
    [Abstract] [Full Text] [Related]

  • 13. [Immunomodulation with fumaric acid. Systemic therapy in psoriasis].
    Sebók B, Schneider I.
    Orv Hetil; 2000 Jan 16; 141(3):129-32. PubMed ID: 10693335
    [Abstract] [Full Text] [Related]

  • 14. Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect.
    Gesser B, Johansen C, Rasmussen MK, Funding AT, Otkjaer K, Kjellerup RB, Kragballe K, Iversen L.
    J Invest Dermatol; 2007 Sep 16; 127(9):2129-37. PubMed ID: 17495961
    [Abstract] [Full Text] [Related]

  • 15. Proteinuria with fumaric acid ester treatment for psoriasis.
    Ogilvie S, Lewis Jones S, Dawe R, Foerster J.
    Clin Exp Dermatol; 2011 Aug 16; 36(6):632-4. PubMed ID: 21771009
    [Abstract] [Full Text] [Related]

  • 16. Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1.
    Lehmann JC, Listopad JJ, Rentzsch CU, Igney FH, von Bonin A, Hennekes HH, Asadullah K, Docke WD.
    J Invest Dermatol; 2007 Apr 16; 127(4):835-45. PubMed ID: 17235328
    [Abstract] [Full Text] [Related]

  • 17. In vitro pharmacokinetics of anti-psoriatic fumaric acid esters.
    Litjens NH, van Strijen E, van Gulpen C, Mattie H, van Dissel JT, Thio HB, Nibbering PH.
    BMC Pharmacol; 2004 Oct 12; 4():22. PubMed ID: 15479475
    [Abstract] [Full Text] [Related]

  • 18. Nail psoriasis improvement in a patient treated with fumaric acid esters.
    Vlachou C, Berth-Jones J.
    J Dermatolog Treat; 2007 Oct 12; 18(3):175-7. PubMed ID: 17538807
    [Abstract] [Full Text] [Related]

  • 19. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
    Balasubramaniam P, Stevenson O, Berth-Jones J.
    Br J Dermatol; 2004 Apr 12; 150(4):741-6. PubMed ID: 15099371
    [Abstract] [Full Text] [Related]

  • 20. Dimethylfumarate for psoriasis: Pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical study.
    Bovenschen HJ, Langewouters AM, van de Kerkhof PC.
    Am J Clin Dermatol; 2010 Apr 12; 11(5):343-50. PubMed ID: 20553063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.